Vanguard Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$396M Buy
11,983,838
+134,291
+1% +$4.44M 0.01% 1158
2025
Q1
$476M Sell
11,849,547
-66,274
-0.6% -$2.66M 0.01% 1023
2024
Q4
$561M Buy
11,915,821
+154,216
+1% +$7.25M 0.01% 973
2024
Q3
$621M Buy
11,761,605
+323,909
+3% +$17.1M 0.01% 909
2024
Q2
$620M Buy
11,437,696
+1,440,620
+14% +$78.1M 0.01% 862
2024
Q1
$701M Sell
9,997,076
-1,019,813
-9% -$71.5M 0.01% 818
2023
Q4
$920M Buy
11,016,889
+273,565
+3% +$22.8M 0.02% 656
2023
Q3
$316M Buy
10,743,324
+472,595
+5% +$13.9M 0.01% 1174
2023
Q2
$335M Buy
10,270,729
+87,397
+0.9% +$2.85M 0.01% 1171
2023
Q1
$358M Buy
10,183,332
+110,238
+1% +$3.88M 0.01% 1101
2022
Q4
$462M Buy
10,073,094
+81,760
+0.8% +$3.75M 0.01% 921
2022
Q3
$484M Buy
9,991,334
+1,031,114
+12% +$50M 0.01% 852
2022
Q2
$352M Buy
8,960,220
+219,096
+3% +$8.61M 0.01% 1075
2022
Q1
$322M Buy
8,741,124
+1,751,405
+25% +$64.5M 0.01% 1252
2021
Q4
$319M Buy
6,989,719
+1,675,188
+32% +$76.4M 0.01% 1305
2021
Q3
$190M Buy
5,314,531
+588,842
+12% +$21M ﹤0.01% 1642
2021
Q2
$93.5M Sell
4,725,689
-173,485
-4% -$3.43M ﹤0.01% 2027
2021
Q1
$114M Buy
4,899,174
+77,185
+2% +$1.8M ﹤0.01% 1881
2020
Q4
$100M Sell
4,821,989
-142,335
-3% -$2.96M ﹤0.01% 1830
2020
Q3
$107M Buy
4,964,324
+393,116
+9% +$8.51M ﹤0.01% 1654
2020
Q2
$108M Sell
4,571,208
-154,528
-3% -$3.64M ﹤0.01% 1637
2020
Q1
$55.7M Buy
4,725,736
+179,746
+4% +$2.12M ﹤0.01% 1826
2019
Q4
$48.2M Buy
4,545,990
+234,549
+5% +$2.49M ﹤0.01% 2121
2019
Q3
$49.1M Buy
4,311,441
+349,944
+9% +$3.98M ﹤0.01% 2075
2019
Q2
$44.6M Buy
3,961,497
+147,849
+4% +$1.66M ﹤0.01% 2166
2019
Q1
$30.9M Buy
3,813,648
+211,736
+6% +$1.71M ﹤0.01% 2309
2018
Q4
$22.8M Buy
3,601,912
+158,554
+5% +$1M ﹤0.01% 2391
2018
Q3
$33.9M Buy
3,443,358
+27,868
+0.8% +$274K ﹤0.01% 2320
2018
Q2
$28.3M Buy
3,415,490
+21,847
+0.6% +$181K ﹤0.01% 2407
2018
Q1
$24.4M Sell
3,393,643
-56,925
-2% -$410K ﹤0.01% 2419
2017
Q4
$28.1M Buy
3,450,568
+62,697
+2% +$511K ﹤0.01% 2348
2017
Q3
$49.1M Buy
3,387,871
+270,375
+9% +$3.92M ﹤0.01% 2053
2017
Q2
$37.7M Buy
3,117,496
+1,168,151
+60% +$14.1M ﹤0.01% 2159
2017
Q1
$25M Buy
1,949,345
+267,437
+16% +$3.44M ﹤0.01% 2350
2016
Q4
$20.4M Sell
1,681,908
-115,429
-6% -$1.4M ﹤0.01% 2413
2016
Q3
$16.5M Sell
1,797,337
-7,276
-0.4% -$66.8K ﹤0.01% 2443
2016
Q2
$17.1M Buy
1,804,613
+334,655
+23% +$3.18M ﹤0.01% 2397
2016
Q1
$10.4M Buy
1,469,958
+185,340
+14% +$1.31M ﹤0.01% 2593
2015
Q4
$13.4M Buy
1,284,618
+42,761
+3% +$447K ﹤0.01% 2474
2015
Q3
$8.31M Buy
1,241,857
+106,405
+9% +$712K ﹤0.01% 2699
2015
Q2
$7.63M Buy
1,135,452
+20,111
+2% +$135K ﹤0.01% 2813
2015
Q1
$7.56M Sell
1,115,341
-129,044
-10% -$875K ﹤0.01% 2783
2014
Q4
$9.97M Sell
1,244,385
-14,891
-1% -$119K ﹤0.01% 2539
2014
Q3
$4.43M Buy
1,259,276
+47,955
+4% +$169K ﹤0.01% 2900
2014
Q2
$5.79M Buy
1,211,321
+95,920
+9% +$458K ﹤0.01% 2764
2014
Q1
$10.6M Buy
1,115,401
+316,337
+40% +$3.01M ﹤0.01% 2461
2013
Q4
$5.19M Buy
799,064
+91,345
+13% +$594K ﹤0.01% 2783
2013
Q3
$5.37M Buy
+707,719
New +$5.37M ﹤0.01% 2705